FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19465811000001104: Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65843601000001117 Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65843701000001110 Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Is a Dabigatran etexilate 150mg capsules true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has specific active ingredient Dabigatran etexilate mesilate false Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dabigatran etexilate false Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Is a Pradaxa true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dabigatran etexilate true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has basis of strength substance Dabigatran etexilate true Inferred relationship Existential restriction modifier
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Has specific active ingredient Dabigatran etexilate mesilate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) 60 capsule 6 x 10 capsules Has AMP True Pradaxa 150mg capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start